Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Two Cancer Treatment Drugs Fail to Make the Grade
On May 3, the FDA's Oncologic Advisory Committee recommended against approval of two cancer treatment drugs: Genasense' by Genta Inc., and RSR13', developed by Allos Therapeutics. Trials for both drugs failed to show that they increased life expectancy, but the companies argued the drugs delayed the onset of symptoms. In the end, the panel found that evidence of the drugs' advantages did not outweigh the risks of side effects.
Three Guidances Promote Minimization of Risks
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
In Rockwell v. Despart, the New York Supreme Court, Third Department, recently revisited a recurring question: When may a landowner seek judicial removal of a covenant restricting use of her land?